Liu, J., Li, C., Qu, W., Leslie, E., Bonifant, C.L., Buzard, G.S., Saavedra, J.E., Keefer, L.K., Waalkes, M.P., 2004. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation 3.